Claritev (CTEV) Q1 2026 earnings review
Top-Line Progress Overshadowed by Cash Burn and Crushing Interest
Claritev's Q1 2026 results present a stark contrast between operational sales progress and financial reality. Management touted 'outperforming on the top and bottom lines,' but the data tells a more sobering story. While revenue grew a stable 5.8% YoY to $244.7M, Adjusted EBITDA margins compressed to 60.0% (down from 61.4% a year ago). The true red flag is cash flow: Free Cash Flow plummeted to $(92.5)M as the company absorbed a massive $129.3M cash interest payment on its $4.57B debt load. Despite slightly raising the bottom end of its FY26 revenue guidance, flat EBITDA guidance implies management expects margin pressure to persist.
🐂 Bull Case
The company has maintained the growth momentum established in 2025, stringing together four consecutive quarters of positive YoY revenue growth, driven by expansion into new verticals.
If you strip away the capital structure, the core business works. Unlevered Free Cash Flow reached $36.8M in Q1, up significantly from $13.1M in Q1 25, proving the software and service model generates cash before debt service.
🐻 Bear Case
Cash paid for interest jumped 57% YoY to $129.3M for the quarter. This interest burden entirely eclipses operational cash generation, driving FCF deep into the red and limiting capital flexibility.
Despite revenue growth, operating leverage is negative. Adjusted EBITDA margin dropped 140 basis points YoY to 60.0%, marking the lowest margin level in the last five quarters as transformation costs eat into profitability.
⚖️ Verdict: 🔴
Bearish. While the 'Vision 2030' strategy is generating top-line stability, the combination of $4.57B in debt, soaring cash interest payments, and shrinking margins makes the equity story highly speculative. The company must drastically accelerate cash generation to service its capital structure.
Key Themes
Narrative vs. Reality: The 'Bottom Line' Contradiction
Management's press release explicitly states the company is 'outperforming on the top and bottom lines.' The data directly contradicts this bottom-line optimism. Net Loss actually worsened YoY from $(71.3)M to $(73.6)M. Furthermore, Adjusted EBITDA margins decelerated to 60.0% from 61.4%. The company is growing sales, but it is currently paying more to get them.
Cash Interest Payments Crippling Free Cash Flow
Claritev's massive debt load is mathematically overwhelming its operational improvements. Cash paid for interest in Q1 26 was a staggering $129.3M, compared to $82.0M in Q1 25. This 57% spike caused Operating Cash Flow to reverse further into negative territory ($-45.8M vs $-30.1M) and drove Free Cash Flow to $-92.5M. The core business simply cannot outrun this interest burden at current growth rates.
Successful Expansion into New Verticals
The company's 'horizontal to vertical' strategy is showing tangible acceleration. Management noted significant bookings in the provider and government verticals, complementing historical strength in the core payer/TPA market. This diversifies Claritev's revenue streams and expands its Total Addressable Market (TAM) beyond pure health insurance payers.
Vision 2030 and AI Monetization
Claritev is leveraging its massive data ecosystem (60M consumers, 1.4M providers) to deploy differentiated AI applications. These AI tools are being used to accelerate progress in affordability and transparency products. The Q1 bookings performance suggests customers are buying into this modernized, tech-enabled product suite over legacy manual claims processing.
Favorable Macro Backdrop Validates Strategy
Management credited 'favorable market trends' for helping drive the top line. Rising healthcare inflation and increased patient financial responsibility structurally benefit Claritev's percentage-of-savings business model. As medical costs rise, the absolute dollar value of the savings Claritev identifies (and takes a cut of) increases concurrently.
Vision 2030 Transformation Costs Weighing on EBITDA
To achieve Adjusted EBITDA of $146.9M, Claritev added back $11.8M in 'Transformation costs' related to Vision 2030 (up from $7.7M a year ago), plus $5.8M in stock-based compensation. While management claims these transformation costs are non-recurring, they have persisted for over a year and represent real cash expenses dragging down actual operational yields.
Other KPIs
Accelerating. Up sharply from $13.1M in Q1 25. This is the most important metric for equity bulls, as it shows the core business's ability to generate cash before debt service is actually improving. Adjusted cash conversion ratio improved to 25% from 9% a year ago.
Decelerating. Down from $28.3M at the end of FY25. The company had to draw $145M on its revolving credit facility (while repaying $40M) just to maintain liquidity through the quarter's heavy cash burn.
Accelerating. Up 20% YoY from $38.9M in Q1 25. The company continues to invest heavily in its platform and software capitalization to support Vision 2030, which further strains near-term free cash flow.
Guidance
Stable/Accelerating mildly. The bottom end of the range was raised by $5M. The midpoint of $992.5M implies a 2.8% YoY growth rate over FY25's $965.4M. Because Q1 grew 5.8%, this guidance implies revenue growth will decelerate to the ~2% range for the remainder of the year.
Stable. The guidance was reaffirmed. The midpoint of $610M implies barely a 1.2% growth over FY25's $602.6M. This confirms that margins will remain pressured throughout the year, trailing revenue growth.
Reversing (Positive expectation). Reaffirmed. Given the company just posted a $(92.5)M Free Cash Flow loss in Q1, achieving even $0M for the full year requires generating nearly $100M in positive FCF over the next three quarters. This is a highly aggressive target that demands flawless execution and likely hinges on the timing of interest payments.
Stable. Reaffirmed. Indicates ongoing sustained investment in internal software and platform infrastructure.
Key Questions
The Bridge to Positive Free Cash Flow
You burned $92.5M in Free Cash Flow this quarter, yet reaffirmed full-year guidance of $0 to $10M. Can you precisely walk us through the cadence of cash flows, working capital releases, and interest payment timing required to generate $100M of positive FCF in the next three quarters?
EBITDA Margin Trajectory
Adjusted EBITDA margin contracted 140 basis points year-over-year in Q1. Given the raised revenue floor but flat EBITDA guidance, should investors expect margins to remain compressed near 60% for the rest of the year, and when do the Vision 2030 investments begin to show positive operating leverage?
Managing the Debt Burden
Cash paid for interest jumped to over $129M in the quarter. With leverage remaining high and interest draining operational cash, what structural actions are you evaluating regarding the capital structure to ensure the debt load doesn't suffocate the equity value?